Bernadich C, Bandi JC, Melin P, Bosch J. Effects of F-180, a new selective vasoconstrictor peptide, compared with Terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension. Hepatology 1998;27:351–356. DOI: 10.1002/hep.510270206. Link to Article Link to FULL FREE PDF
Demiselle J, Fage N, Radermacher P, Asfar P. Vasopressin and its analogues in shock states: a review. Ann Intensive Care 2020;10(1):9. doi: 10.1186/s13613-020-0628-2 Link to Article Link to FULL FREE PDF
“TERLIVAZ/Terlipressin Injection, USP.” FDA.gov, U.S. Food and Drug Administration, 2023, https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022231s000lbl.pdf Link to Package Insert
Mårtensson J, Gordon AC. Terlipressin or norepinephrine, or both in septic shock? Intensive Care Med. 2018 Nov;44(11):1964-1966. doi: 10.1007/s00134-018-5290-x. Epub 2018 Jul 13. PMID: 30006892. Link to Article Link to FULL FREE PDF
Jozwiak M. Alternatives to norepinephrine in septic shock: Which agents and when? J Intensive Med. 2022 Jun 12;2(4):223-232. doi: 10.1016/j.jointm.2022.05.001. PMID: 36788938; PMCID: PMC9924015. Link to Article Link to FULL FREE PDF
Russell JA, Gordon AC, Williams MD, Boyd JH, Walley KR, Kissoon N. Vasopressor Therapy in the Intensive Care Unit. Semin Respir Crit Care Med. 2021 Feb;42(1):59-77. doi: 10.1055/s-0040-1710320. Epub 2020 Aug 20. PMID: 32820475. Link to Article Link to FULL FREE PDF
Leone M, Albanèse J, Delmas A, Chaabane W, Garnier F, Martin C. Terlipressin in catecholamine-resistant septic shock patients. Shock. 2004 Oct;22(4):314-9. doi: 10.1097/01.shk.0000136097.42048.bd. PMID: 15377885. Link to Article and FULL FREE PDF
Morelli A, Ertmer C, Rehberg S, Lange M, Orecchioni A, Cecchini V, Bachetoni A, D’Alessandro M, Van Aken H, Pietropaoli P, Westphal M. Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study. Crit Care. 2009;13(4):R130. doi: 10.1186/cc7990. Epub 2009 Aug 10. PMID: 19664253; PMCID: PMC2750187. Link to Article Link to FULL FREE PDF
Liu ZM, Chen J, Kou Q, Lin Q, Huang X, Tang Z, Kang Y, Li K, Zhou L, Song Q, Sun T, Zhao L, Wang X, He X, Wang C, Wu B, Lin J, Yuan S, Gu Q, Qian K, Shi X, Feng Y, Lin A, He X; Study Group of investigators; Guan XD. Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial. Intensive Care Med. 2018 Nov;44(11):1816-1825. doi: 10.1007/s00134-018-5267-9. Epub 2018 Jul 3. PMID: 29971593. Link to Article Link to FULL FREE PDF
Sahoo P, Kothari N, Goyal S, Sharma A, Bhatia PK. Comparison of Norepinephrine and Terlipressin vs Norepinephrine Alone for Management of Septic Shock: A Randomized Control Study. Indian J Crit Care Med. 2022 Jun;26(6):669-675. doi: 10.5005/jp-journals-10071-24231. PMID: 35836627; PMCID: PMC9237141. Link to Article Link to FULL FREE PDF
Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, Machado FR, Mcintyre L, Ostermann M, Prescott HC, Schorr C, Simpson S, Wiersinga WJ, Alshamsi F, Angus DC, Arabi Y, Azevedo L, Beale R, Beilman G, Belley-Cote E, Burry L, Cecconi M, Centofanti J, Coz Yataco A, De Waele J, Dellinger RP, Doi K, Du B, Estenssoro E, Ferrer R, Gomersall C, Hodgson C, Møller MH, Iwashyna T, Jacob S, Kleinpell R, Klompas M, Koh Y, Kumar A, Kwizera A, Lobo S, Masur H, McGloughlin S, Mehta S, Mehta Y, Mer M, Nunnally M, Oczkowski S, Osborn T, Papathanassoglou E, Perner A, Puskarich M, Roberts J, Schweickert W, Seckel M, Sevransky J, Sprung CL, Welte T, Zimmerman J, Levy M. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021 Nov;47(11):1181-1247. doi: 10.1007/s00134-021-06506-y. Epub 2021 Oct 2. PMID: 34599691; PMCID: PMC8486643. Link to Article Link to FULL FREE PDF
Zhu Y, Huang H, Xi X, Du B. Terlipressin for septic shock patients: a meta-analysis of randomized controlled study. J Intensive Care. 2019 Mar 12;7:16. doi: 10.1186/s40560-019-0369-1. PMID: 30923620; PMCID: PMC6419496. Link to Article Link to FULL FREE PDF
Huang L, Zhang S, Chang W, Xia F, Liu S, Yang Y, Qiu H. Terlipressin for the treatment of septic shock in adults: a systematic review and meta-analysis. BMC Anesthesiol. 2020 Mar 5;20(1):58. doi: 10.1186/s12871-020-00965-4. PMID: 32138657; PMCID: PMC7057452. Link to Article Link to FULL FREE PDF
Williams MD, Russell JA. Terlipressin or norepinephrine in septic shock: do we have the answer? J Thorac Dis. 2019 May;11(Suppl 9):S1270-S1273. doi: 10.21037/jtd.2019.05.07. PMID: 31245106; PMCID: PMC6560608. Link to Article Link to FULL FREE PDF
Yao RQ, Xia DM, Wang LX, Wu GS, Zhu YB, Zhao HQ, Liu Q, Xia ZF, Ren C, Yao YM. Clinical Efficiency of Vasopressin or Its Analogs in Comparison With Catecholamines Alone on Patients With Septic Shock: A Systematic Review and Meta-Analysis. Front Pharmacol. 2020 May 6;11:563. doi: 10.3389/fphar.2020.00563. PMID: 32435192; PMCID: PMC7218087. Link to Article Link to FULL FREE PDF
Wang J, Shi M, Huang L, Li Q, Meng S, Xu J, Xue M, Xie J, Liu S, Huang Y. Addition of terlipressin to norepinephrine in septic shock and effect of renal perfusion: a pilot study. Ren Fail. 2022 Dec;44(1):1207-1215. doi: 10.1080/0886022X.2022.2095286. PMID: 35856162; PMCID: PMC9307113. Link to Article Link to FULL FREE PDF
Schultz J, Andersen A, Lyhne MD, Arcanjo DDR, Kjaergaard B, Simonsen U, Nielsen-Kudsk JE. Terlipressin Increases Systemic and Lowers Pulmonary Arterial Pressure in Experimental Acute Pulmonary Embolism. Crit Care Med. 2020 Apr;48(4):e308-e315. doi: 10.1097/CCM.0000000000004243. PMID: 32205621. Link to (NOT FREE) Article
Levy B, Fritz C, Tahon E, Jacquot A, Auchet T, Kimmoun A. Vasoplegia treatments: the past, the present, and the future. Crit Care. 2018 Feb 27;22(1):52. doi: 10.1186/s13054-018-1967-3. PMID: 29486781; PMCID: PMC6389278. Link to Article Link to FULL FREE PDF
Subedi A, Suresh Kumar VC, Sharma Subedi A, Sapkota B. A Review of Hepatorenal Syndrome. Cureus. 2021 Jul 1;13(7):e16084. doi: 10.7759/cureus.16084. PMID: 34367745; PMCID: PMC8330394. Link to Article Link to FULL FREE PDF
Wang H, Liu A, Bo W, Feng X, Hu Y. Terlipressin in the treatment of hepatorenal syndrome: A systematic review and meta-analysis. Medicine (Baltimore). 2018 Apr;97(16):e0431. doi: 10.1097/MD.0000000000010431. PMID: 29668606; PMCID: PMC5916651. Link to Article Link to FULL FREE PDF
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018 Aug;69(2):406-460. doi: 10.1016/j.jhep.2018.03.024. Epub 2018 Apr 10. Erratum in: J Hepatol. 2018 Nov;69(5):1207. PMID: 29653741. Link to Article Link to FULL FREE PDF
Wong F, Pappas SC, Curry MP, Reddy KR, Rubin RA, Porayko MK, Gonzalez SA, Mumtaz K, Lim N, Simonetto DA, Sharma P, Sanyal AJ, Mayo MJ, Frederick RT, Escalante S, Jamil K; CONFIRM Study Investigators. Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome. N Engl J Med. 2021 Mar 4;384(9):818-828. doi: 10.1056/NEJMoa2008290. PMID: 33657294. Link to Article Link to FULL FREE PDF
